Entries by admin

PROF. ADAM R. HALL

Wake-Forest University, School of Biomedical Engineering and Sciences, Ph.D., Applied and Materials Sciences, University of North Carolina at Chapel Hill

Martin Huber, Ph.D.

CEO   Dr.Huber is a co-founder of Quantapore and the inventor of Quantapore’s sequencing technology. Martin holds an M.S. and a Ph.D. in Genetics and Biochemistry (cum laude) from the University of Vienna, Austria. He has over 20 years of experience in biotechnology start-ups both in Europe and the US. During this time he held positions of […]

Sascha C. Dennstedt, MD, MSc

President Dr. Dennstedt is a co-founder of Quantapore and responsible for business planning and development efforts as well as managing early-stage operations. Dr. Dennstedt is an experienced entrepreneur and has successfully invested in multiple Biotech start-ups as well as in other commercial enterprises.

Quantapore Inc. recently closed its Series B round of Preferred Stock financing

Quantapore Inc. recently closed its Series B round of Preferred Stock financing. In May 2014 Quantapore closed a Series B with a total investment volume of up to $35M from  undisclosed investors. Funds will be used to finalize the development of Quantapore’s proprietary sequencing technology as well as the commercialization of its sequencing platform.